Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

KKR provides bespoke financing to Australia’s Family Doctor

Global private equity firm KKR has provided a financing solution to Family Doctor, an Australian GP clinic network, to support its growth and acquisitions. As HBI understands, Dr. Aziz will retain 100% ownership and KKR’s Asia Pacific Credit strategy intends to start with an initial A$170 million facility. 

European Health Data Space published — will enter into force later in March

On March 5th 2025 the European Health Data Space (EHDS) Regulation was published in the Official Journal of the European Union. The European Commission describes the EHDS as "a game changer for healthcare in Europe" that aims to transform how health data is accessed, used, and shared across the EU.

New contract for UK GPs giving them more money and flexibility

A new GP contract will “fix the front door” of the NHS and bring back the family doctor, the government has announced. The new deal agreed with the British Medical Association (BMA) will free up doctors from box-ticking targets to concentrate on patients and take first steps to end the “8am scramble” for appointments. 

Clariane’s 2024 results boost share price

The share price of listed pan-European French elderly care group Clariane shot up 33% last week, after the release of 2024 results showing a return to profitability.

Activos presents elderly care roadmap at European Parliament

Spain-based pan-European REIT Healthcare Activos has presented a “strategic roadmap” for expanding Europe’s elderly care capacity to MEPs at the European Parliament, given that the continent’s 80+ population will roughly double by 2050. 

Fresenius surpasses expectations in 2024, driven by Kabi growth and strategic restructuring

Fresenius, Germany’s largest for-profit hospital group, has just released its 2024 annual results, and CEO Michael Sen’s “Future Fresenius” strategy is in full swing. The company beat market expectations for FY24 earnings, with strong performance from its hospital drug unit, Kabi. The unit saw a 21% jump in EBIT year-on-year, hitting €340 million, driven by solid revenue growth and better productivity.

Find Us